What is the STLN stock price prediction for next 2 weeks?

According to our price prediction algorithm,Starling Oncology, Inc. (STLN) price will be around $6.79 in the next 2 weeks. This means it will increase by 9.462903225806444 from the last closing price. This prediction may vary from other time period filters for STLN stock.

What can be the highest Possible price of STLN stock in next 2 weeks?

Our forecast algorithm expects that in 2 weeks, STLN can achieve the highest price of $7.18 which is 15.854547164830853 higher than last closing price. This prediction may vary from other time period filters for STLN stock.

What can be the lowest Possible price of STLN stock in next 2 weeks?

As per the forecast and algorithmic analysis, STLN stock price can be as low as $6.38 which is 2.9689359796932444 higher than the current price in the next 2 weeks. This prediction may vary from other time period filters for STLN stock.

Will STLN stock go high in the next 2 weeks?

Yes, our stock forecasting algorithm shows that STLN stock will gain9.462903225806444 in the next 2 weeks. This prediction may vary from other time period filters for STLN stock.

What is STLN stock last closing price?

Last closing price of STLN stock was $6.20.

What is STLN stock price prediction?

STLN stock price prediction means predicting the future closing prices of STLN stock based on its past data. Our forecasting algorithm uses various machine learning and deep learning techniques to forecast the future behavior of STLN stock in a certain time period.

How we predict STLN stock future prices?

If you are searching for STLN stock forecast, analysis or price prediction, then you might be wondering what Starling Oncology, Inc. (STLN) will do in the future. Our STLN price predictions are based on various Machine Learning based algorithms with an aim to try and predict future price movements. This STLN price prediction will likely answer most of your questions.

How frequent we update STLN stock predictions?

We are updating the forecasts for the STLN stock on daily basis.

Is using ML forecasting for STLN stock a good way?

Yes. Stock Price Prediction is one of the most exciting applications of Machine Learning. By leveraging data from the past, it is possible to use forecasting models to make accurate predictions about future stock prices. This can be incredibly beneficial for investors and traders, as it gives them the ability to make more informed decisions about when to buy and sell. Investing in the stock market can be a risky endeavor, but leveraging Machine Learning can make it a bit less daunting and more profitable.

Is the Prediction for STLN stock same for all the time periods?

No, the prediction for STLN stock is not same for all time periods. The forecasts may vary depending on the differences in the time period.

Starling Oncology, Inc. Stock Forecast and Stock Price Prediction

Stock Forecast Chart

Stock Price Prediction Summary

Closed Price$6.200.49%Since 2 Weeks

Predicted Price$6.799.46%For 2 Weeks

Upper Predicted Price$7.1815.85%For 2 Weeks

Lower Predicted Price$6.382.97%For 2 Weeks

Forecast Score Based on 2 Weeks

Based on our forecast, the price of STLN will rise by +9.46% over the next 2 Weeks and hit $6.79 by Thursday, September 24, 2026. In that time frame, STLN's share price is expected to range between $6.38 and $7.18.

BearishAverageBullish

Date	Predicted Lower	Predicted	Predicted Upper
Sep 24, 2026	6.38	6.79	7.18
Sep 23, 2026	6.55	6.88	7.23
Sep 22, 2026	6.38	6.67	6.96
Sep 21, 2026	6.28	6.51	6.75
Sep 18, 2026	6.33	6.51	6.70
Sep 17, 2026	6.35	6.49	6.66
Sep 16, 2026	6.47	6.59	6.72
Sep 15, 2026	6.26	6.37	6.48
Sep 14, 2026	6.12	6.21	6.31
Sep 11, 2026	6.13	6.22	6.31

STLN shares fell -1.43% in Thursday, September 10, 2026's trading session, dropping from a previous close of $6.29 to move at $6.20. The stock demonstrated notable intraday movement (see STLN's key stats for a full breakdown), fluctuating between $6.14 and $6.50, a +5.95% trading range. While recent weeks have seen some volatility, STLN has managed to secure a -2.21% drop over the past 2 weeks. The downward price movement was accompanied by decreased trading volume, with approximately 680K shares changing hands, 166.4K fewer than the previous session. This amounted to $4.22M in total market activity.

Will STLN Continue Its Upward Trend?

According to analyst ratings and projections for STLN, Starling Oncology, Inc. shares are anticipated to increase by +13.68%, potentially reaching $7.18 per share by September 24, 2026. Short-term technical indicators currently suggest a neutral sentiment for STLN. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 10 positive trading days within the past 30 sessions. Based on the STLN stock forecast, now is a good time to buy STLN stock because its current trading price is -8.64% below our predicted value, hinting at a possible overvaluation. For deeper insights, view our sentiment analysis on STLN covering social and institutional perspectives.

STLN Technical Momentum: Overbought, Oversold, or Neutral?

An analysis of Relative Strength Index (RSI) indicators provides insight into STLN's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 51.91% to 52.64%) suggest the stock is in a neutral to slightly bearish momentum phase.Insights into STLN's shareholder base show how institutional investors are positioning themselves during these momentum shifts

Starling Oncology Short-Term Forecasts

STLN Forecast For Next 5 Days

Our algorithm anticipates Starling Oncology (STLN) stock could hit $6.50 by Sep 17, 2026. This represents a +4.91% fall from today's price, following a - change over the past five days.

STLN Forecast For Next 30 Days

Based on analysis of market trends, the outlook for Starling Oncology, Inc. (STLN) stock over the next 30 days is largely positive. Price forecasts suggest an average target of $6.36, which would mean a +2.58% increase from the current price of $6.20. Projections for this period range from a high of $7.03 to a low of $5.72.

STLN Forecast For Next 90 Days

Our proprietary market analysis suggests predictions for Starling Oncology's price over the next three months point to a rise. STLN stock is expected to peak at $28.24 on Oct 14, 2026 after potentially dipping to $18.47 on Sep 21, 2026. On average, STLN is likely to trade around $24.51 in the coming 90 days.

Starling Oncology Stock Forecast 2025

Based on our predictive models, Starling Oncology (STLN) is expected to trade between $18.47 and $32.53 throughout 2026. This would result in an average price of $24.89, potentially offering investors a +301.45% return from current levels.

Starling Oncology, Inc. Monthly Forecast 2026–2027

September 2026

According to our latest forecast models, Starling Oncology, Inc. (STLN) is positioned to show a strong performance in September 2026. The price is predicted to move between $18.47 and $26.37, settling at an average of $22.37. This could translate to a +260.81% gain.

October 2026

Based on current market signals, Starling Oncology, Inc. is projected to trend october 2026. We forecast a trading range from $22.19 to $28.24, with a likely average price of $25.21. Investors could expect a potential return of +306.61%.

November 2026

Our predictive algorithms indicate Starling Oncology, Inc. stock may see a shift in November 2026. The expected range spans $23.04–$27.49, with an average target of $25.08. This represents a positive outlook and a possible gain of +304.52%.

December 2026

Analyzing established trends, Starling Oncology, Inc. looks set to move in December 2026. Projections place the stock between $21.65 and $32.53, averaging around $25.96. This suggests a +318.71% gain from current levels.

January 2027

Market indicators suggest Starling Oncology, Inc. could experience notable changes during January 2027. Prices could fluctuate within $22.51 to $29.71, with a midpoint forecast of $24.83. The stock might deliver a +300.48% gain.

February 2027

Forecasting for February 2027, models estimate that Starling Oncology, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $20.33 and $27.97, averaging $24.52. This signals a positive trajectory with potential returns around +295.48%.

March 2027

According to our latest forecast models, Starling Oncology, Inc. (STLN) is positioned to show a strong performance in March 2027. The price is predicted to move between $23.03 and $26.99, settling at an average of $25.00. This could translate to a +303.23% gain.

April 2027

Based on current market signals, Starling Oncology, Inc. is projected to trend april 2027. We forecast a trading range from $22.71 to $26.63, with a likely average price of $25.12. Investors could expect a potential return of +305.16%.

May 2027

Our predictive algorithms indicate Starling Oncology, Inc. stock may see a shift in May 2027. The expected range spans $21.78–$31.57, with an average target of $26.06. This represents a positive outlook and a possible gain of +320.32%.

June 2027

Analyzing established trends, Starling Oncology, Inc. looks set to move in June 2027. Projections place the stock between $21.72 and $27.26, averaging around $25.01. This suggests a +303.39% gain from current levels.

July 2027

Market indicators suggest Starling Oncology, Inc. could experience notable changes during July 2027. Prices could fluctuate within $21.28 to $30.91, with a midpoint forecast of $25.60. The stock might deliver a +312.90% gain.

August 2027

Forecasting for August 2027, models estimate that Starling Oncology, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $22.02 and $29.30, averaging $25.99. This signals a positive trajectory with potential returns around +319.19%.

September 2027

According to our latest forecast models, Starling Oncology, Inc. (STLN) is positioned to show a strong performance in September 2027. The price is predicted to move between $22.89 and $26.09, settling at an average of $24.36. This could translate to a +292.90% gain.

STLN's history of dividends and stock splits also plays a role in long-term investor confidence.